BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao YN, Baiyisaiti A, Wong CW, Hsu SH, Qi R. Polyurethane Nanoparticle-Loaded Fenofibrate Exerts Inhibitory Effects on Nonalcoholic Fatty Liver Disease in Mice. Mol Pharm 2018;15:4550-7. [PMID: 30188729 DOI: 10.1021/acs.molpharmaceut.8b00548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mahmoudi A, Jamialahmadi T, Johnston TP, Sahebkar A. Impact of fenofibrate on NAFLD/NASH: A genetic perspective. Drug Discov Today 2022:S1359-6446(22)00194-5. [PMID: 35569762 DOI: 10.1016/j.drudis.2022.05.007] [Reference Citation Analysis]
2 Huang AP, Lai DM, Hsu YH, Tsai HH, Su CY, Hsu SH. An anti-inflammatory gelatin hemostatic agent with biodegradable polyurethane nanoparticles for vulnerable brain tissue. Mater Sci Eng C Mater Biol Appl 2021;121:111799. [PMID: 33579446 DOI: 10.1016/j.msec.2020.111799] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Cao YN, Yue SS, Wang AY, Xu L, Hu YT, Qiao X, Wu TY, Ye M, Wu YC, Qi R. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity. J Ethnopharmacol 2022;:115146. [PMID: 35304272 DOI: 10.1016/j.jep.2022.115146] [Reference Citation Analysis]
4 Tao Y, Xu S, Wang J, Xu L, Zhang C, Chen K, Lian Z, Zhou J, Xie H, Zheng S, Xu X. Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders. Front Pharmacol 2020;11:921. [PMID: 32848718 DOI: 10.3389/fphar.2020.00921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang Y, Wang J, Ren J, Wang J, Qiao F, Zhang M, Du Z. Activation of peroxisome proliferator‐activated receptor‐α stimulated lipid catabolism in liver of largemouth bass, Micropterus salmoides. Aquacult Nutr 2021;27:2749-58. [DOI: 10.1111/anu.13400] [Reference Citation Analysis]
6 He XL, He YM, Zhang D, Li HS, Zhang Q, Yuan SS, Zhang Z, Wang YY, Liu CH, Fan CH, Li YH, Zheng M, Yang HJ, Zhou P. Efficacy and Mechanism of a Chinese Classic Prescription of Yueju in Treating Nonalcoholic Steatohepatitis and Protecting Hepatocytes from Apoptosis. Evid Based Complement Alternat Med 2020;2020:8888040. [PMID: 33178326 DOI: 10.1155/2020/8888040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Desai SK, Mondal D, Bera S. Polyurethane-functionalized starch nanocrystals as anti-tuberculosis drug carrier. Sci Rep 2021;11:8331. [PMID: 33859215 DOI: 10.1038/s41598-021-86767-1] [Reference Citation Analysis]
8 Moosavian SA, Sathyapalan T, Jamialahmadi T, Sahebkar A. The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review. Bioinorg Chem Appl 2021;2021:4041415. [PMID: 34659388 DOI: 10.1155/2021/4041415] [Reference Citation Analysis]
9 Maeda H, Ishima Y, Saruwatari J, Mizuta Y, Minayoshi Y, Ichimizu S, Yanagisawa H, Nagasaki T, Yasuda K, Oshiro S, Taura M, McConnell MJ, Oniki K, Sonoda K, Wakayama T, Kinoshita M, Shuto T, Kai H, Tanaka M, Sasaki Y, Iwakiri Y, Otagiri M, Watanabe H, Maruyama T. Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH. J Control Release 2021;341:457-74. [PMID: 34856227 DOI: 10.1016/j.jconrel.2021.11.039] [Reference Citation Analysis]
10 Zhao R, Zhu M, Zhou S, Feng W, Chen H. Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease. Front Chem 2020;8:407. [PMID: 32548088 DOI: 10.3389/fchem.2020.00407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]